CIBC Asset Management
RNAM

CIBC Asset Management’s Avidity Biosciences RNAM Stock Holding History

CIBC Asset Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,432
Closed -$392K – 1422
2025
Q4 		$392K Buy
+5,432
New +$351K ﹤0.01% 870

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

CIBC Asset Management's RNAM Position: Q1 2026 in Review

CIBC Asset Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 5,432 shares — an estimated $392K sold.

CIBC Asset Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $392K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • CIBC Asset Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • CIBC Asset Management sold 5,432 Avidity Biosciences shares in Q1 2026, an estimated $392K.
  • CIBC Asset Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • CIBC Asset Management's Avidity Biosciences position peaked at $392K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on CIBC Asset Management's 13F filing for Q1 2026, filed 12 May 2026.